Mustang Bio (MBIO) Q1 2026 Earnings
MBIO·Reported May 5, 2026·After market close
Diluted EPS came in at $-0.14 (-180.0% YoY), beat the $-140.00 consensus by $139.86.
Diluted EPS
$-0.14beat by $139.86
Consensus: $-140.00
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Mustang Bio's Q1 2026 earnings report.
Mustang Bio (MBIO) reported Q1 2026 earnings on May 5, 2026 after market close.
Mustang Bio reported diluted EPS of $-0.14 for Q1 2026.
EPS beat the consensus estimate of $-140.00 by $139.86.
Compared to the same quarter a year prior, diluted EPS declined 180.0% from $-0.05.
You can read the 10-Q periodic report (0001104659-26-055598) directly on SEC EDGAR. The filing index links above go to sec.gov.